Skip to main content
OpenTrials
Completed

NCT Number: NCT04541316

Neo-angiogenesis in Inguinal Henia Implant ProFlor

The investigation is aimed at specifically demonstrating the ingrowth of newly formed vascular elements within ProFlor, a 3D dynamic responsive implant for inguinal hernia repair

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

About this study

Biopsy specimen were excised at defined postoperative stages from patients who underwent hernia repair with the 3D prosthesis named ProFlor. Scope of the study was to determine the presence, quantity and quality of the vascular elements ingrowth within the implant fabric. Histology revealed the presence of multiple angiogenetic clusters that, starting from the early stage post-implantation, increased in number and degree of maturation. In the long term, the detected vascular components assumed the typical aspect of mature veins and arteries complete in all components. The development of fully developed vascular structures, ingrowing together with other components of the abdominal wall already described in literature, seems to finalize a regenerative response. This kind of behavior, being the expected result from a device intended for the cure of inguinal hernia and its degenerative source, seems to be coherent with the pathogenesis of the disease.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who underwent inguinal hernia repair with the 3D dynamic responsive device named ProFlor
  • Patients undergoing recurrent inguinal hernia repair after primary repair with the 3D dynamic responsive device named ProFlor
  • Patients undergoing surgical procedure in the groin area after inguinal hernia repair with the 3D dynamic responsive device named ProFlor

Exclusion criteria

  • immunosoppressive therapy, > ASA 4 classification

Treatment and study plan

ProFlor inguinal hernia device

Device

Inguinal hernia repair

Primary outcomes

  1. Ingrowth of Newly Formed Vascular Elements Within Hernia Implant ProFlor

    Time frame: 3-5 weeks post-implantation

    Post-operative assessment of neo-angiogenesis within hernia implant ProFlor at short term post-implantation

  2. Ingrowth of Newly Formed Vascular Elements Within Hernia Implant ProFlor

    Time frame: 3-4 months post implantation

    Post-operative assessment of neo-angiogenesis within hernia implant ProFlor at midterm post-implantation

  3. Ingrowth of Newly Formed Vascular Elements Within Hernia Implant ProFlor

    Time frame: 6-8 months post implantation

    Post-operative assessment of neo-angiogenesis within hernia implant ProFlor at midterm post-implantation

Sponsors and collaborators

Lead sponsor

University of Cagliari

Other

Registry information

Official study title

Neo-angiogenesis in 3D Dynamic Responsive Implant for Inguinal Hernia Repair ProFlor

Important dates

Study start
2013
Primary completion
2020
Study completion
2020
First posted
Sep 9, 2020
Registry last updated
Sep 10, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.